Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

AMG 172 First in Human Study in Patients With Kidney Cancer

This study has been completed.
Information provided by (Responsible Party):
Amgen Identifier:
First received: December 16, 2011
Last updated: March 23, 2016
Last verified: March 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2015
  Primary Completion Date: November 2014 (Final data collection date for primary outcome measure)